Volcano Corporation
3661 Valley Centre Drive
Suite 200
San Diego,
CA 92130
United States - Map
Phone: 916-638-8008
Fax: 858-720-0325
Web Site: http://www.volcanotherapeutics.com
| Volcano Corporation designs, develops, manufactures, and commercializes a suite of intravascular ultrasound (IVUS) and functional measurement (FM) products. Its IVUS products consist of ultrasound consoles, and single-procedure disposable phased array and rotational IVUS imaging catheters, as well as functionality options, such as virtual histology, IVUS tissue characterization, and ChromaFlo stent apposition analysis. The companys FM products include consoles, and pressure and flow guide wires to measure the pressure and flow characteristics of blood around plaque enabling physicians to gauge the plaques physiological impact on blood flow and pressure. It also involves in developing forward-looking IVUS, catheters, image-guided therapy catheters, and ultra-high resolution optical coherence tomography systems and catheters. The company markets its IVUS consoles as stand-alone units or customized units that can be integrated into various hospital-based interventional surgical suites called catheterization laboratories. It offers its products to enhance the diagnosis and treatment of vascular heart diseases by improving the efficiency and efficacy of existing percutaneous interventional (PCI) therapy procedures in the coronary or peripheral arteries. The company serves physicians and technicians who perform PCI procedures in hospitals, and other personnel who make purchasing decisions on behalf of hospitals through its direct sales force and distributors, as well as through supply and distribution agreements with third parties. As of December 31, 2008, Volcano Corporation had installed 3,200 IVUS consoles and 800 FM consoles. Volcano Corporation was formerly known as Volcano Therapeutics, Inc. The company was founded in 2000 and is headquartered in San Diego, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. R. Scott Huennekens , 45
Chief Exec. Officer, Pres |
$
840.00K |
$
2.78M | Mr. John T. Dahldorf , 52
Chief Fin. Officer, Principal Accounting Officer, Sec. and Gen. Mang. |
$
385.00K |
$
1.67M | Mr. John F. Sheridan , 53
Exec. VP of R&D and Operations |
$
330.00K |
$
703.00K | Mr. Michel Lussier MS BME, MBA, 52
Pres of Volcano Europe & Clinical and Scientific Affairs |
$
475.00K |
$
0 | Mr. Vincent J. Burgess , 44
Group Pres of Advanced Imaging Systems |
$
355.00K |
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.67% Nasdaq 
Profile
